Enanta Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ENTA Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
12 Feb 25	BuyUS$256,050	Jay Luly	Individual	45,000	US$5.69
06 Dec 24	SellUS$41,445	Jay Luly	Individual	5,142	US$8.06
06 Dec 24	SellUS$18,401	Brendan Luu	Individual	2,283	US$8.06
06 Dec 24	SellUS$18,401	Tara Kieffer	Individual	2,283	US$8.06
06 Dec 24	SellUS$20,883	Paul Mellett	Individual	2,591	US$8.06
06 Dec 24	SellUS$20,883	Yat Or	Individual	2,591	US$8.06
06 Dec 24	SellUS$6,980	Scott Rottinghaus	Individual	866	US$8.06

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ENTA?
Owner Type	Number of Shares	Ownership Percentage
General Public	1,119,829	5.24%
Individual Insiders	1,432,219	6.7%
Hedge Funds	5,585,780	26.1%
Institutions	13,238,753	61.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 81.33% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.95%	Farallon Capital Management, L.L.C.	2,122,262	US$12.2m	0.66%	0.07%
9.92%	Krensavage Asset Management, LLC	2,116,586	US$12.2m	-0.04%	5.91%
9.46%	BlackRock, Inc.	2,018,669	US$11.6m	-1.03%	no data
9.41%	The Vanguard Group, Inc.	2,007,433	US$11.6m	1.17%	no data
6.31%	Millennium Management LLC	1,346,932	US$7.8m	50.2%	0.01%
3.99%	Marshall Wace LLP	850,890	US$4.9m	-8.52%	0.01%
3.98%	Acadian Asset Management LLC	849,424	US$4.9m	0%	0.01%
3.88%	Jay Luly	826,729	US$4.8m	8.25%	no data
2.77%	Stonepine Capital Management LLC	590,742	US$3.4m	78%	1.51%
2.32%	Geode Capital Management, LLC	494,205	US$2.8m	3.56%	no data
2.17%	Renaissance Technologies LLC	463,600	US$2.7m	-6.91%	no data
2.13%	State Street Global Advisors, Inc.	455,394	US$2.6m	-1.21%	no data
1.8%	D. E. Shaw & Co., L.P.	383,320	US$2.2m	-9.08%	no data
1.7%	Yat Or	362,335	US$2.1m	1.52%	no data
1.5%	Northern Trust Global Investments	320,512	US$1.8m	-17.3%	no data
1.36%	Trexquant Investment LP	290,059	US$1.7m	113%	0.02%
1.32%	Dimensional Fund Advisors LP	282,302	US$1.6m	-4.98%	no data
1.3%	Eaton Vance Management	277,359	US$1.6m	15.8%	no data
1.25%	Jacobs Levy Equity Management Inc	266,768	US$1.5m	-8.01%	0.01%
0.98%	Morgan Stanley, Investment Banking and Brokerage Investments	208,756	US$1.2m	-78.7%	no data
0.97%	UBS Asset Management AG	205,877	US$1.2m	7.86%	no data
0.83%	Sio Capital Management, LLC	177,004	US$1.0m	0%	0.28%
0.75%	Charles Schwab Investment Management, Inc.	159,801	US$920.7k	3.21%	no data
0.68%	Two Sigma Advisers, LP	146,100	US$841.8k	-6.53%	no data
0.59%	Tang Capital Management, LLC	126,655	US$729.8k	0%	0.03%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/18 11:17
End of Day Share Price	2025/05/16 00:00
Earnings	2025/03/31
Annual Earnings	2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Enanta Pharmaceuticals, Inc. is covered by 19 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Brian Skorney	Baird
Geoffrey Meacham	Barclays
Patrick Trucchio	Berenberg